V.A. Moar

TL;DR: There were no significant differences between the children in the treated and untreated groups in standing and supine blood pressures, or fourteen tests of ability, and methyldopa seems safe to use in pregnancy and is probably preferable to other drugs from the point of view of the neonate and child.

TL;DR: If the pathological factors of smoking, hypertension and preeclampsia could be prevented, the number of SGA pregnancies in this population would be reduced by about 50%.

TL;DR: It is concluded that maternal hypertension is associated with slight developmental delay in early childhood and there are some indications that treatment with methyldopa may reduce this effect.

TL;DR: There was a significantly higher death rate when the mother was pre-eclamptic, and the incidence of seven other morbidity factors was increased; among the survivors perinatal morbidity was also markedly increased when the baby was abnormal.

TL;DR: In the SFD and LFD groups some significant correlations were found between size and developmental scores; but none were found among AFD children; and when all the children were considered together and birthweight included as an additional variable the differences in developmental scores between the groups were much reduced.